Back to Search
MONICA SCARSELLA, D.O.
D.O.
Neurology Physician
NPI: 1225560634IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
OS024741(PA)5101027094(MI)
CMS Specialties
PrimaryNEUROLOGY
Education
LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE, ERIE
Class of 2017
Research & Publications (20)
G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors.
PMID 19010844·Clin Cancer Res·2008
7-preclinical
Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.
PMID 18483253·Cancer Res·2008
7-preclinical
Che-1 activates XIAP expression in response to DNA damage.
PMID 18049476·Cell Death Differ·2008
7-preclinical
Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.
PMID 17932567·J Clin Invest·2007
7-preclinical
Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis.
PMID 17714938·Eur J Cancer·2007
7-preclinical
Therapeutic integration of c-myc and bcl-2 antisense molecules with docetaxel in a preclinical model of hormone-refractory prostate cancer.
PMID 17654511·Prostate·2007
7-preclinical
Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint.
PMID 17157788·Cancer Cell·2006
7-preclinical
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma.
PMID 16809434·FASEB J·2006
8-other
Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts.
PMID 16648562·Mol Cancer Ther·2006
7-preclinical
Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide.
PMID 16288862·Eur J Cancer·2005
7-preclinical
Potentiation of the antitumoral activity of gemcitabine and paclitaxel in combination on human breast cancer cells.
PMID 16210917·Cancer Biol Ther·2005
4-observational
Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
PMID 15756025·Clin Cancer Res·2005
7-preclinical
In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines.
PMID 15691389·J Transl Med·2005
8-other
Brain distribution and efficacy as chemosensitizer of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumors.
PMID 15645126·Int J Oncol·2005
7-preclinical
In vivo administration of liposomal vincristine sensitizes drug-resistant human solid tumors.
PMID 15146568·Int J Cancer·2004
7-preclinical
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice.
PMID 15054877·Int J Cancer·2004
7-preclinical
Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity.
PMID 14627985·Oncogene·2003
7-preclinical
Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.
PMID 14614022·Clin Cancer Res·2003
4-observational
Alpha-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy.
PMID 12569582·Int J Cancer·2003
7-preclinical
Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.
PMID 12082531·Oncogene·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 9500 EUCLID AVE, SUITE RC25
CLEVELAND, OH 44195 - Phone
- (216) 444-2200
Quick Facts
- NPI
- 1225560634
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile